Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-50 |
Sentence |
denotes |
Circulating Fatty Acid Synthase in pregnant women: |
T2 |
51-126 |
Sentence |
denotes |
Relationship to blood pressure, maternal metabolism and newborn parameters. |
T3 |
127-232 |
Sentence |
denotes |
The enzyme FASN (fatty acid synthase) is potentially related with hypertension and metabolic dysfunction. |
T4 |
233-280 |
Sentence |
denotes |
FASN is highly expressed in the human placenta. |
T5 |
281-433 |
Sentence |
denotes |
We aimed to investigate the relationship circulating FASN has with blood pressure, maternal metabolism and newborn parameters in healthy pregnant women. |
T6 |
434-705 |
Sentence |
denotes |
Circulating FASN was assessed in 115 asymptomatic pregnant women in the second trimester of gestation along with C-peptide, fasting glucose and insulin, post-load glucose lipids, HMW-adiponectin and blood pressure (the latter was assessed in each trimester of gestation). |
T7 |
706-752 |
Sentence |
denotes |
At birth, newborns and placentas were weighed. |
T8 |
753-814 |
Sentence |
denotes |
FASN expression was also able to be assessed in 80 placentas. |
T9 |
815-1095 |
Sentence |
denotes |
Higher circulating FASN was associated with lower systolic blood pressure (SBP), with a more favourable metabolic phenotype (lower fasting glucose and insulin, post load glucose, HbAc1, HOMA-IR and C-peptide), and with lower placental and birth weight (all p < 0.05 to p < 0.001). |
T10 |
1096-1219 |
Sentence |
denotes |
Placental FASN expression related positively to circulating FASN (p < 0.005) and negatively to placental weight (p < 0.05). |
T11 |
1220-1303 |
Sentence |
denotes |
Our observations suggest a physiological role of placental FASN in human pregnancy. |
T12 |
1304-1533 |
Sentence |
denotes |
Future studies will clarify whether circulating FASN of placental origin does actually regulate placental and fetal growth, and (thereby) has a favourable influence on the pregnant mother's insulin sensitivity and blood pressure. |